IOTA-AI - AI-assisted automated detection of ovarian cancer on ultrasound imaging
From 01-09-2021 to 31-08-2023
Description
Ovarian cancer is the seventh most common cancer in women and constitutes the most lethal gynecological malignancy. Timely diagnosis and appropriate referral to gynecological oncology expert centers is pivotal to improve patient outcomes. Ultrasonography (US) is a readily available, cheap and harmless technique, and is widely accepted as first-line imaging modality for assessment of ovarian masses.
Currently, the ADNEX model is the best available ultrasound-based mathematical model to differentiate between benign and several types of malignant ovarian tumors. However, it relies on the ability of the US operator to reliably (manually) locate, delineate and measure the tumor area and its associated features. Previously, we developed automated feature detection methods in collaboration with ESAT-STADIUS and General Electric, where we demonstrated the effectiveness of a deep convolutional neural network (DCNN) approach. The objective of this C3 project is to clinically validate these models, and to develop a fully-automated classification model for ovarian cancer detection based on 2D and 3D ultrasound data.
Team
- Bart De Moor, Associated partner
- Nikhil Sindhwani, Co-promoter
- Dirk Timmerman, Co-promoter (External)
- Wouter Froyman, Coordinator (External)
Financing
Funding: KU Leuven - Internal Funding KU Leuven
Program/Grant Type: C3 - KU Leuven Category 3 Funding
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.